长江生命科技发盈警 预计中期取得股东应占亏损约 1.5 亿港元 同比盈转亏
According to the announcement from CKLIFE SCIENCES, the group expects to incur a shareholder loss of approximately HKD 150 million for the six months ending June 30, 2025, compared to a shareholder profit of HKD 1 million in the same period of 2024. The shift from profit to loss is attributed to the company's earlier decision to increase R&D investment. Overall, the group's operations have remained stable during the reporting period and up to the date of this announcement
According to the announcement from CKLIFE SCIENCES (00775), the group expects to incur a shareholder's attributable loss of approximately HKD 150 million for the six months ending June 30, 2025, compared to a shareholder's attributable profit of HKD 1 million for the same period in 2024. The shift from profit to loss is attributed to the company's earlier decision to increase research and development investment. Overall, the group's operations have remained stable during the reporting period and up to the date of this announcement
